Cargando…

Ferroptosis Enhanced Diabetic Renal Tubular Injury via HIF-1α/HO-1 Pathway in db/db Mice

BACKGROUND: Ferroptosis is a recently identified iron-dependent form of cell death as a result of increased reactive oxygen species (ROS) and lipid peroxidation. In this study, we investigated whether ferroptosis aggravated diabetic nephropathy (DN) and damaged renal tubules through hypoxia-inducibl...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Xiaomeng, Wang, Shuo, Sun, Zhencheng, Dong, Hengbei, Yu, Haitian, Huang, Mengxiu, Gao, Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930496/
https://www.ncbi.nlm.nih.gov/pubmed/33679620
http://dx.doi.org/10.3389/fendo.2021.626390
_version_ 1783660112635756544
author Feng, Xiaomeng
Wang, Shuo
Sun, Zhencheng
Dong, Hengbei
Yu, Haitian
Huang, Mengxiu
Gao, Xia
author_facet Feng, Xiaomeng
Wang, Shuo
Sun, Zhencheng
Dong, Hengbei
Yu, Haitian
Huang, Mengxiu
Gao, Xia
author_sort Feng, Xiaomeng
collection PubMed
description BACKGROUND: Ferroptosis is a recently identified iron-dependent form of cell death as a result of increased reactive oxygen species (ROS) and lipid peroxidation. In this study, we investigated whether ferroptosis aggravated diabetic nephropathy (DN) and damaged renal tubules through hypoxia-inducible factor (HIF)-1α/heme oxygenase (HO)-1 pathway in db/db mice. METHODS: Db/db mice were administered with or without ferroptosis inhibitor Ferrostatin-1 treatment, and were compared with db/m mice. RESULTS: Db/db mice showed higher urinary albumin-to-creatinine ratio (UACR) than db/m mice, and Ferrostatin-1 reduced UACR in db/db mice. Db/db mice presented higher kidney injury molecular-1 and neutrophil gelatinase-associated lipocalin in kidneys and urine compared to db/m mice, with renal tubular basement membranes folding and faulting. However, these changes were ameliorated in db/db mice after Ferrostatin-1 treatment. Fibrosis area and collagen I were promoted in db/db mouse kidneys as compared to db/m mouse kidneys, which was alleviated by Ferrostatin-1 in db/db mouse kidneys. HIF-1α and HO-1 were increased in db/db mouse kidneys compared with db/m mouse kidneys, and Ferrostatin-1 decreased HIF-1α and HO-1 in db/db mouse kidneys. Iron content was elevated in db/db mouse renal tubules compared with db/m mouse renal tubules, and was relieved in renal tubules of db/db mice after Ferrostatin-1 treatment. Ferritin was increased in db/db mouse kidneys compared with db/m mouse kidneys, but Ferrostatin-1 reduced ferritin in kidneys of db/db mice. Diabetes accelerated nicotinamide adenine dinucleotide phosphate (NADPH) oxidase-derived ROS formation in mouse kidneys, but Ferrostatin-1 prevented ROS formation derived by NADPH oxidases in db/db mouse kidneys. The increased malondialdehyde (MDA) and the decreased superoxide dismutase (SOD), catalase (CAT), glutathione peroxidases (GSH-Px) were detected in db/db mouse kidneys compared to db/m mouse kidneys, whereas Ferrostatin-1 suppressed MDA and elevated SOD, CAT, and GSH-Px in db/db mouse kidneys. Glutathione peroxidase 4 was lower in db/db mouse kidneys than db/m mouse kidneys, and was exacerbated by Ferrostatin-1 in kidneys of db/db mice. CONCLUSIONS: Our study indicated that ferroptosis might enhance DN and damage renal tubules in diabetic models through HIF-1α/HO-1 pathway.
format Online
Article
Text
id pubmed-7930496
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-79304962021-03-05 Ferroptosis Enhanced Diabetic Renal Tubular Injury via HIF-1α/HO-1 Pathway in db/db Mice Feng, Xiaomeng Wang, Shuo Sun, Zhencheng Dong, Hengbei Yu, Haitian Huang, Mengxiu Gao, Xia Front Endocrinol (Lausanne) Endocrinology BACKGROUND: Ferroptosis is a recently identified iron-dependent form of cell death as a result of increased reactive oxygen species (ROS) and lipid peroxidation. In this study, we investigated whether ferroptosis aggravated diabetic nephropathy (DN) and damaged renal tubules through hypoxia-inducible factor (HIF)-1α/heme oxygenase (HO)-1 pathway in db/db mice. METHODS: Db/db mice were administered with or without ferroptosis inhibitor Ferrostatin-1 treatment, and were compared with db/m mice. RESULTS: Db/db mice showed higher urinary albumin-to-creatinine ratio (UACR) than db/m mice, and Ferrostatin-1 reduced UACR in db/db mice. Db/db mice presented higher kidney injury molecular-1 and neutrophil gelatinase-associated lipocalin in kidneys and urine compared to db/m mice, with renal tubular basement membranes folding and faulting. However, these changes were ameliorated in db/db mice after Ferrostatin-1 treatment. Fibrosis area and collagen I were promoted in db/db mouse kidneys as compared to db/m mouse kidneys, which was alleviated by Ferrostatin-1 in db/db mouse kidneys. HIF-1α and HO-1 were increased in db/db mouse kidneys compared with db/m mouse kidneys, and Ferrostatin-1 decreased HIF-1α and HO-1 in db/db mouse kidneys. Iron content was elevated in db/db mouse renal tubules compared with db/m mouse renal tubules, and was relieved in renal tubules of db/db mice after Ferrostatin-1 treatment. Ferritin was increased in db/db mouse kidneys compared with db/m mouse kidneys, but Ferrostatin-1 reduced ferritin in kidneys of db/db mice. Diabetes accelerated nicotinamide adenine dinucleotide phosphate (NADPH) oxidase-derived ROS formation in mouse kidneys, but Ferrostatin-1 prevented ROS formation derived by NADPH oxidases in db/db mouse kidneys. The increased malondialdehyde (MDA) and the decreased superoxide dismutase (SOD), catalase (CAT), glutathione peroxidases (GSH-Px) were detected in db/db mouse kidneys compared to db/m mouse kidneys, whereas Ferrostatin-1 suppressed MDA and elevated SOD, CAT, and GSH-Px in db/db mouse kidneys. Glutathione peroxidase 4 was lower in db/db mouse kidneys than db/m mouse kidneys, and was exacerbated by Ferrostatin-1 in kidneys of db/db mice. CONCLUSIONS: Our study indicated that ferroptosis might enhance DN and damage renal tubules in diabetic models through HIF-1α/HO-1 pathway. Frontiers Media S.A. 2021-02-18 /pmc/articles/PMC7930496/ /pubmed/33679620 http://dx.doi.org/10.3389/fendo.2021.626390 Text en Copyright © 2021 Feng, Wang, Sun, Dong, Yu, Huang and Gao http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Feng, Xiaomeng
Wang, Shuo
Sun, Zhencheng
Dong, Hengbei
Yu, Haitian
Huang, Mengxiu
Gao, Xia
Ferroptosis Enhanced Diabetic Renal Tubular Injury via HIF-1α/HO-1 Pathway in db/db Mice
title Ferroptosis Enhanced Diabetic Renal Tubular Injury via HIF-1α/HO-1 Pathway in db/db Mice
title_full Ferroptosis Enhanced Diabetic Renal Tubular Injury via HIF-1α/HO-1 Pathway in db/db Mice
title_fullStr Ferroptosis Enhanced Diabetic Renal Tubular Injury via HIF-1α/HO-1 Pathway in db/db Mice
title_full_unstemmed Ferroptosis Enhanced Diabetic Renal Tubular Injury via HIF-1α/HO-1 Pathway in db/db Mice
title_short Ferroptosis Enhanced Diabetic Renal Tubular Injury via HIF-1α/HO-1 Pathway in db/db Mice
title_sort ferroptosis enhanced diabetic renal tubular injury via hif-1α/ho-1 pathway in db/db mice
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930496/
https://www.ncbi.nlm.nih.gov/pubmed/33679620
http://dx.doi.org/10.3389/fendo.2021.626390
work_keys_str_mv AT fengxiaomeng ferroptosisenhanceddiabeticrenaltubularinjuryviahif1aho1pathwayindbdbmice
AT wangshuo ferroptosisenhanceddiabeticrenaltubularinjuryviahif1aho1pathwayindbdbmice
AT sunzhencheng ferroptosisenhanceddiabeticrenaltubularinjuryviahif1aho1pathwayindbdbmice
AT donghengbei ferroptosisenhanceddiabeticrenaltubularinjuryviahif1aho1pathwayindbdbmice
AT yuhaitian ferroptosisenhanceddiabeticrenaltubularinjuryviahif1aho1pathwayindbdbmice
AT huangmengxiu ferroptosisenhanceddiabeticrenaltubularinjuryviahif1aho1pathwayindbdbmice
AT gaoxia ferroptosisenhanceddiabeticrenaltubularinjuryviahif1aho1pathwayindbdbmice